Your trusted destination for CME, CPD & Medical Education across the Middle East.
Arbor Biotechnologies
Dr. Devyn M. Smith is an American biotechnology executive and scientist with more than 20 years of experience in cell and gene therapy development, pharmaceutical research, and biotechnology company leadership. He is the Chief Executive Officer of Arbor Biotechnologies, a biotechnology company focused on discovering and developing next-generation genetic medicines, including advanced gene-editing therapies.
Dr. Smith earned his PhD in Genetics from Harvard Medical School. His academic research resulted in publications in leading scientific journals and helped establish his foundation in genetics and therapeutic development. He also holds a Master of Science in Biology and a Bachelor of Science in Zoology.
Before joining Arbor Biotechnologies in April 2021, Dr. Smith served as Chief Operating Officer and Head of Strategy at Sigilon Therapeutics. During his tenure, he contributed to the company's growth and development of its research and development capabilities, helping scale the organisation from approximately 10 to more than 100 employees.
Earlier in his career, Dr. Smith held several leadership positions at Pfizer, including Chief Operating Officer of its UK-based Neusentis research unit, which focused on discovering and developing cell therapies. His responsibilities covered research operations, business strategy, and the advancement of regenerative medicine programmes.

dmg events
dmg events